CARDIOVASCULAR EFFECTS OF ANTHRACYCLINE-LIKE CHEMOTHERAPY AGENTS JOHN N. HAMATY FACC, FACOI.
Hemodynamic Monitoring in the CCU Edward G. Hamaty Jr., D.O. FACCP, FACOI.
Joshua M. Crasner,DO,FACC,FACOI. 50 million people USA SBP>115 incr risk CAD/CVA Q 20mm incr=2X risk JNC-8 has changed aggressive Tx Pseudo-HTN.
Evidence Based Medicine Examples Edward G. Hamaty Jr., D.O. FACCP, FACOI.
Pharmacologic Treatment of Chronic Systolic Heart Failure John N. Hamaty D.O. FACC, FACOI.
How To Be Healthy Without Killing Yourself B Bottenberg, D.O., FNLA, FACOI.
